FAF
CRL icon

Fjarde Ap-fonden’s Charles River Laboratories CRL Stock Holding History

Fjarde Ap-fonden’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-30
Closed -$5K – 502
2025
Q1 		$5K Sell
30
-9,800
-100% -$1.64M ﹤0.01% 519
2024
Q4 		$1.81M Buy
9,830
+4,200
+75% +$809K 0.02% 483
2024
Q3 		$1.11M Buy
+5,630
New +$1.17M 0.01% 501
2024
Q1 		$1.77M Buy
6,530
+1,800
+38% +$430K 0.02% 502
2023
Q4 		$1.12M Buy
4,730
+3,500
+285% +$688K 0.01% 511
2023
Q3 		$241K Sell
1,230
-1,800
-59% -$370K ﹤0.01% 532
2023
Q2 		$637K Sell
3,030
-1,000
-25% -$199K 0.01% 522
2023
Q1 		$813K Sell
4,030
-2,600
-39% -$589K 0.01% 511
2022
Q4 		$1.44M Sell
6,630
-6,700
-50% -$1.46M 0.02% 491
2022
Q3 		$2.85M Hold
13,330
– – 0.04% 456
2022
Q2 		$2.85M Sell
13,330
-5,900
-31% -$1.44M 0.04% 456
2022
Q1 		$5.46M Sell
19,230
-100
-0.5% -$30.8K 0.05% 368
2021
Q4 		$7.28M Buy
19,330
+3,530
+22% +$1.37M 0.06% 307
2021
Q3 		$6.52M Sell
15,800
-1,500
-9% -$623K 0.06% 328
2021
Q2 		$6.4M Buy
+17,300
New +$5.78M 0.06% 343

Other funds holding CRL

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Nomura Holdings
Nomura Holdings Tokyo, Japan $85.4B AUM 91.09% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return

Fjarde Ap-fonden's CRL Position: Q2 2025 in Review

Fjarde Ap-fonden sold out of Charles River Laboratories (CRL) in Q2 2025, closing a stake of 30 shares — an estimated $5K sold.

Fjarde Ap-fonden first reported a position in CRL in Q2 2021 and held it in 15 quarters. The position peaked at $7.28M in Q4 2021. 519 funds tracked by Wall St. Rank hold CRL as of Q2 2025.

  • Fjarde Ap-fonden reported no remaining Charles River Laboratories position as of Q2 2025 after selling out during the quarter.
  • Fjarde Ap-fonden sold 30 Charles River Laboratories shares in Q2 2025, an estimated $5K.
  • Fjarde Ap-fonden first reported a position in Charles River Laboratories in Q2 2021 and held it in 15 quarters.
  • Fjarde Ap-fonden's Charles River Laboratories position peaked at $7.28M in Q4 2021.
  • 519 funds tracked by Wall St. Rank held Charles River Laboratories as of Q2 2025.

Based on Fjarde Ap-fonden's 13F filing for Q2 2025, filed 1 Aug 2025.